Regeneron Pharmaceuticals, Inc.

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

86,975

Value ($000)

67,080

Weight

0.6%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	67,080	0.6%	86,975	12/31/2025
2025 Q3	10/24/2025	52,806	0.5%	91,727	9/30/2025
2025 Q2	7/30/2025	52,454	0.5%	99,913	6/30/2025
2025 Q1	4/24/2025	56,712	0.6%	96,473	3/31/2025
2024 Q4	1/28/2025	72,642	0.6%	106,091	12/31/2024
2024 Q3	10/25/2024	101,697	0.9%	109,481	9/30/2024
2024 Q2	7/17/2024	113,529	1.0%	103,680	6/30/2024
2024 Q1	4/23/2024	78,561	0.8%	87,274	3/31/2024
2023 Q4	2/1/2024	57,930	0.6%	61,446	12/31/2023
2023 Q3	11/3/2023	35,959	0.4%	43,917	9/30/2023
2023 Q2	8/1/2023	12,025	0.1%	16,736	6/30/2023
2023 Q1	5/2/2023	10,452	0.1%	12,720	3/31/2023
2022 Q4	3/2/2023	9,089	0.1%	12,597	12/31/2022
2022 Q3	10/25/2022	8,221	0.1%	11,934	9/30/2022
2022 Q2	7/26/2022	6,505	0.1%	11,005	6/30/2022
2022 Q1	4/13/2022	7,622	0.1%	10,913	3/31/2022
2021 Q4	2/14/2022	6,847	0.1%	10,842	12/31/2021
2021 Q3	11/12/2021	6,480	0.1%	10,707	9/30/2021
2021 Q2	8/13/2021	5,968	0.1%	10,685	6/30/2021
2021 Q1	4/14/2021	4,795	0.1%	10,135	3/31/2021
2020 Q4	1/14/2021	77	0.0%	160	12/31/2020